Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tiffany Schwass"'
Autor:
Alice Wang, Nishi Karunasinghe, Lindsay D. Plank, Shuotun Zhu, Sue Osborne, Charis Brown, Karen Bishop, Tiffany Schwass, Sofian Tijono, Michael Holmes, Jonathan Masters, Roger Huang, Christine Keven, Lynnette R. Ferguson, Ross Lawrenson
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Androgen deprivation therapy (ADT) for men with prostate cancer (PCa) results in accelerated bone loss and increased risk of bone fracture. The aim of the present study was to evaluate serum bone markers—sclerostin, Dickkopf-1 (DKK-1) and
Externí odkaz:
https://doaj.org/article/d34afd32928b417ab49bef681506016d
Autor:
Alice Wang, Nishi Karunasinghe, Lindsay Plank, Shuotun Zhu, Sue Osborne, Karen Bishop, Charis Brown, Tiffany Schwass, Jonathan Masters, Michael Holmes, Roger Huang, Christine Keven, Lynnette Ferguson, Ross Lawrenson
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 11 (2017)
Introduction: Reduction in bone mineral density (BMD) is a common side effect of androgen deprivation therapy (ADT). We aimed to examine the cross-sectional and longitudinal variation in BMD and associated bone markers in patients with nonmetastatic
Externí odkaz:
https://doaj.org/article/7e4cf81ad0a94171a672eb4e138665b4
Autor:
Nishi Karunasinghe, Sue Osborne, Tiffany Schwass, Jonathan Masters, Karen S. Bishop, Shuotun Zhu, Roger Huang, Charis Brown, Ross Lawrenson, Alice Wang, Christine Keven, Lindsay D. Plank, Sofian M. Tijono, Michael Holmes, Lynnette R. Ferguson
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Androgen deprivation therapy (ADT) for men with prostate cancer (PCa) results in accelerated bone loss and increased risk of bone fracture. The aim of the present study was to evaluate serum bone markers—sclerostin, Dickkopf-1 (DKK-1) and osteoprot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c761fefdca916d6e7467ac35cbc6b74c
http://europepmc.org/articles/PMC8295319
http://europepmc.org/articles/PMC8295319
Autor:
Tiffany Schwass, Lindsay D. Plank, Christine Keven, Lynnette R. Ferguson, Jonathan Masters, Roger Huang, Shuotun Zhu, Charis Brown, Sue Osborne, Karen S. Bishop, Alice Wang, Ross Lawrenson, Michael Holmes, Nishi Karunasinghe
Publikováno v:
Clinical Medicine Insights. Oncology
Clinical Medicine Insights: Oncology, Vol 11 (2017)
Clinical Medicine Insights: Oncology, Vol 11 (2017)
Introduction: Reduction in bone mineral density (BMD) is a common side effect of androgen deprivation therapy (ADT). We aimed to examine the cross-sectional and longitudinal variation in BMD and associated bone markers in patients with nonmetastatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6543bae71b1b56089a0a4377197aaa88
https://pubmed.ncbi.nlm.nih.gov/29051709
https://pubmed.ncbi.nlm.nih.gov/29051709